The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
Open accessAbstract
To evaluate the role of lipoprotein(a) (Lp(a] in patients with cerebrovascular disease (CVD), lipid parameters were compared with a control group (CO). Additionally, the Lp(a) serum levels were investigated in a coronary artery disease (CAD) group. The CO was made up of 37 healthy persons (age: 54.5 +/- 7.7, 26 males and 11 females), the CVD group included 46 patients with sustained transient ischemic attack (TIA) prolonged reversible ischemic neurologic deficits (PRIND) and cerebral infarction (CI) (age: 53.6 +/- 9.7, 32 males and 14 females), and the CAD group was made up of 28 survivors of myocardial infarctions (age: 52.5 +/- 8.1, 18 males and 10 females). The median values of Lp(a) in CVD were significantly higher than in the CO (p less than 0.01) and did not differ significantly from the CAD. Total TC, HDL-C, TG, LDL-C and the ratio of LDL-C/HDL-C did not show any significant difference between the control and cerebrovascular disease group. For quantification of the vascular lesions of the carotid system, a Duplex Doppler score system was used. The score correlated with Lp(a) in patients between 40 to 65 years of age (r = 0.34, p less than 0.01). Thus, we conclude that Lp(a) is not only a risk factor for CAD but also for CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
MATSUMOTO, N., WHISNANT, J. P., KURLAND, L. T., & OKAZAKI, H. (1973) · Stroke · doi:10.1161/01.str.4.1.20 · Cited by 366
Basilar artery occlusion: clinical and radiological correlation.
Archer, C. R., & Horenstein, S. (1977) · Stroke · doi:10.1161/01.str.8.3.383 · Cited by 328
Immunochemical quantification of human plasma Lp(a) lipoprotein
Albers, J. J., & Hazzard, W. R. (1974) · Lipids · doi:10.1007/bf02533209 · Cited by 217
Incidence of asymptomatic extracranial arterial disease.
Hennerici, M., Aulich, A., Sandmann, W., & Freund, H. J. (1981) · Stroke · doi:10.1161/01.str.12.6.750 · Cited by 215
Albers, J. J., Cabana, V. G., Warnick, G. R., & Hazzard, W. R. (1975) · Metabolism · doi:10.1016/0026-0495(75)90098-0 · Cited by 152
GEOGRAPHIC AND OCCUPATIONAL OF RISK FACTORS IN CARDIOVASCULAR DISEASES IN JAPAN
Komachi, Y., Iida, M., Shimamoto, T., Chikayama, Y., Takahashi, H., Konishi, M., & Tominaga, S. (1971) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.35.189 · Cited by 116
Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts
Havekes, L. M., Vermeer, B. J., Brugman, T., & EMEIS, J. J. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)81153-2 · Cited by 106
Five methods for determining low-density lipoprotein cholesterol compared.
Demacker, P. N. M., Hijmans, A., Brenninkmeijer, B. J., Jansen, A. P. H., & Laar, A. V. '. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.11.1797 · Cited by 99
Maartmann‐Moe, K., & Berg, K. (1981) · Clinical Genetics · doi:10.1111/j.1399-0004.1981.tb01047.x · Cited by 86
Estimation of Survivorship in Chronic Disease: The “Actuarial” Method
Elveback, L. R. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501449 · Cited by 76
Uptake of Lp(a) lipoprotein by cultured fibroblasts
Floren, C.-H., Albers, J. J., & Bierman, E. L. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(81)80179-9 · Cited by 67
Quantitative genetic studies of the human plasma Lp(a) lipoprotein
Albers, J. J., WAHL, P. W., & Hazzard, W. R. (1974) · Biochemical Genetics · doi:10.1007/bf00486079 · Cited by 65
Serum Lipid Levels in Angiographically Defined Coronary Artery Disease
Cohn, P. F., GABBAY, S. I., & WEGLICKI, W. B. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-3-241 · Cited by 62
Serum Lipid and Cholesterol Levels in Cerebrovascular Disease
Meyer, J. S., Waltz, A. G., HESS, J. W., et al. (1959) · Archives of Neurology · doi:10.1001/archneur.1959.03840030061006 · Cited by 55
Jürgens, G., & Kostner, G. M. (1974) · Immunogenetics · doi:10.1007/bf01564093 · Cited by 49
Self-citationResearch related to underlying mechanisms in atherosclerosis.
Steinberg, D. (1979) · Circulation · doi:10.1161/01.cir.60.7.1559 · Cited by 34
Davignon, J., Lussier‐Cacan, S., Ortin-George, M., Lelièvre, M., Bertagna, C., GATTEREAU, A., & Fontaine, A. (1977) · PubMed Central · Cited by 29
Cited by
Boerwinkle, E., Leffert, C. C., Lin, J., Lackner, C., Chiesa, G., & Hobbs, H. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115855 · Cited by 962
Nordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575
Rosengren, A., Wilhelmsen, L., Eriksson, E., Risberg, B., & Wedel, H. (1990) · BMJ · doi:10.1136/bmj.301.6763.1248 · Cited by 539
Jenner, J. L., Ordovas, J. M., Lamon-Fava, S., Schaefer, M. M., Wilson, P. W., Castelli, W. P., & Schaefer, E. J. (1993) · Circulation · doi:10.1161/01.cir.87.4.1135 · Cited by 338
Prospective study of endogenous tissue plasminogen activator and risk of stroke
Ridker, P. M., Hennekens, C. H., Manson, J. E., Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Vaughan, D. E., Hennekens, C. H., & Stampfer, M. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90064-7 · Cited by 305
Metadata
- Authors
- Zenker, G., Költringer, P., Boné, G., Niederkorn, K., Pfeiffer, K., & Jürgens, G.
- Venue
- Stroke
- Published
- 1986-09
- Volume
- 17
- Issue
- 5
- Pages
- 942-945
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1992992795
- Cited by
- 329
- References
- 20
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.